The latest closing stock price for Foghorn Therapeutics as of November 20, 2024 is 7.86.
An investor who bought $1,000 worth of Foghorn Therapeutics stock at the IPO in 2020 would have $-566 today, roughly -1 times their original investment - a -18.84% compound annual growth rate over 4 years.
The all-time high Foghorn Therapeutics stock closing price was 25.88 on December 18, 2020.
The Foghorn Therapeutics 52-week high stock price is 10.25, which is 30.4% above the current share price.
The Foghorn Therapeutics 52-week low stock price is 2.70, which is 65.6% below the current share price.
The average Foghorn Therapeutics stock price for the last 52 weeks is 6.43.
An investor who bought $1,000 worth of Foghorn Therapeutics stock at the IPO in 2020 would have $-566 today, roughly -1 times their original investment - a -18.84% compound annual growth rate over 4 years.
The all-time high Foghorn Therapeutics stock closing price was 25.88 on December 18, 2020.
The Foghorn Therapeutics 52-week high stock price is 10.25, which is 30.4% above the current share price.
The Foghorn Therapeutics 52-week low stock price is 2.70, which is 65.6% below the current share price.
The average Foghorn Therapeutics stock price for the last 52 weeks is 6.43.